Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8802142 | UCB INC | Pharmaceutical compositions comprising levetiracetam and process for their preparation |
Jun, 2031
(7 years from now) | |
US8802142 (Pediatric) | UCB INC | Pharmaceutical compositions comprising levetiracetam and process for their preparation |
Dec, 2031
(7 years from now) |
Keppra is owned by Ucb Inc.
Keppra contains Levetiracetam.
Keppra has a total of 2 drug patents out of which 0 drug patents have expired.
Keppra was authorised for market use on 30 November, 1999.
Keppra is available in tablet;oral dosage forms.
The generics of Keppra are possible to be released after 07 December, 2031.
Drugs and Companies using LEVETIRACETAM ingredient
Market Authorisation Date: 30 November, 1999
Treatment: NA
Dosage: TABLET;ORAL